Are you Dr. Volkmann?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 47 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 UCLA Medical Plaza
University of California Los Angeles David Geffen Schoo
Los Angeles, CA 90095Phone+1 310-824-2448Fax+1 310-825-2572- Is this information wrong?
Summary
- Dr. Elizabeth Volkmann, MD is a rheumatologist in Los Angeles, California. She is currently licensed to practice medicine in California. She is affiliated with Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 2011 - 2013
David Geffen School of Medicine at UCLAClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Summary for Clinicians: Clinical Practice Guideline for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations.Tanzib Hossain, Sydney B Montesi, Carey C Thomson, Joseph K Ruminjo, Richard M Silver, Marya Ghazipura, Ganesh Raghu, Volkmann, E.> ;Annals of the American Thoracic Society. 2024 Jan 1
- CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.Sarah Luebker, Tracy M Frech, Shervin Assassi, Brian Skaug, Jessica K Gordon, Kimberly Lakin, Elana J Bernstein, Yiming Luo, Virginia D Steen, Ami A Shah, Laura K Humm...> ;Rheumatology. 2023 Oct 3
- 2 citationsAnti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study.Viggo Hamberg, Azita Sohrabian, Elizabeth R Volkmann, Marie Wildt, Anna Löfdahl, Dirk M Wuttge, Roger Hesselstrand, Göran Dellgren, Gunilla Westergren-Thorsson, Johan ...> ;Arthritis Research & Therapy. 2023 Sep 4
- Join now to see all
Press Mentions
Tofacitinib May Have Possible Protective Effect Against ILD in RAMarch 24th, 2023- Call It Preclinical or Subclinical, ILD in RA Needs to Be TrackedMarch 3rd, 2023
- Future of Systemic Sclerosis Treatment Will Likely Be Combination TherapyOctober 22nd, 2022
- Join now to see all
Professional Memberships
- Fellows-in-Training 3rd year
Hospital Affiliations
Ronald Reagan UCLA Medical CenterLos Angeles, California- UCLA Medical Center-Santa MonicaSanta Monica, California
